Axogen, inc reports 2023 fourth quarter and full-year financial results

Alachua, fla. and tampa, fla., march 05, 2024 (globe newswire) -- axogen, inc. (nasdaq: axgn), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the fourth quarter and full-year ended december 31, 2023.

AXGN Ratings Summary

AXGN Quant Ranking